Friday, 29th March
Register
Log in
Password recovery
Menu
COVID-19
Alzheimer’s & Dementia
Cancer
Diabetes
Heart & Lung
Infection
Men’s
Women’s
Mental
Muscular
Surgery
Innovation
Sexual Health
Paediatrics
Lifestyle
NHS
Medico-Legal
Neurodiversity
Reproductive Health
Nutrition
Aesthetic
CPD
Global Reach
Drugs
[esi adrotate group="1" cache="private" ttl="0"]
Karen Aiach
About
Latest Posts
Karen Aiach
Karen Aiach is CEO and founder of Lysogene, a biotech company developing gene therapy for central nervous system disorders.
Latest posts by Karen Aiach
(
see all
)
Gene therapy for nervous system disorders
- 16th April 2017
Gene therapy for nervous system disorders